Trademark: 90835844
Status Date
Monday, September 11, 2023
Filing Date
Monday, July 19, 2021
Published for Opposition
Tuesday, December 14, 2021
Abandoned Date
Monday, September 11, 2023
5 pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases
The mark consists of a two dimensional representation of three interconnected cubes, with a single cube resting on top of two cubes.
Sep 11, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 11, 2023
Abandonment - No Use Statement Filed
Feb 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2023
Sou Extension 2 Granted
Feb 6, 2023
Sou Extension 2 Filed
Feb 6, 2023
Sou Teas Extension Received
Jul 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 18, 2022
Sou Extension 1 Granted
Jul 18, 2022
Sou Extension 1 Filed
Jul 18, 2022
Sou Teas Extension Received
Feb 8, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 14, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 14, 2021
Published For Opposition
Nov 24, 2021
Notification Of Notice Of Publication E-Mailed
Nov 9, 2021
Approved For Pub - Principal Register
Nov 9, 2021
Examiner's Amendment Entered
Nov 9, 2021
Notification Of Examiners Amendment E-Mailed
Nov 9, 2021
Examiners Amendment E-Mailed
Nov 9, 2021
Examiners Amendment -Written
Nov 8, 2021
Assigned To Examiner
Sep 22, 2021
Notice Of Design Search Code E-Mailed
Sep 21, 2021
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
